tiprankstipranks
Advertisement
Advertisement

NKTR Stock Latest News

Canaccord sees potential Apogee buyout as ‘huge win’ for sector
The FlyCanaccord sees potential Apogee buyout as ‘huge win’ for sector
19d ago
ABBV
APGE
Nektar Stockholders Approve Governance and Incentive Plan Changes
PremiumCompany Announcements
Nektar Stockholders Approve Governance and Incentive Plan Changes
1M ago
8K
NKTR
Nektar management to meet with Piper Sandler
PremiumThe Fly
Nektar management to meet with Piper Sandler
1M ago
NKTR
5 Healthcare Stocks Set to Join the Russell 3000
PremiumMarket News
5 Healthcare Stocks Set to Join the Russell 3000
2M ago
QSI
AGEN
3 Best Healthcare Stocks to Buy in May 2026, According to Analysts
PremiumMarket News
3 Best Healthcare Stocks to Buy in May 2026, According to Analysts
2M ago
CRNX
LEGN
Nektar price target lowered to $80 from $95 at Wedbush
PremiumThe FlyNektar price target lowered to $80 from $95 at Wedbush
2M ago
NKTR
Nektar Therapeutics Charts Aggressive Path With REZPEG
Premium
Company Announcements
Nektar Therapeutics Charts Aggressive Path With REZPEG
2M ago
NKTR
Nektar Therapeutics Establishes New Equity Distribution Agreement
Premium
Company Announcements
Nektar Therapeutics Establishes New Equity Distribution Agreement
2M ago
8K
NKTR
Julian Harrison Reiterates Buy on Nektar, Citing Robust REZPEG Program and Strong Balance Sheet; Maintains $178 Price Target
PremiumRatings
Julian Harrison Reiterates Buy on Nektar, Citing Robust REZPEG Program and Strong Balance Sheet; Maintains $178 Price Target
2M ago
NKTR
Nektar price target raised to $192 from $105 at Piper Sandler
PremiumThe Fly
Nektar price target raised to $192 from $105 at Piper Sandler
2M ago
NKTR
Nektar Therapeutics: Strong Cash Position and Late‑Stage Autoimmune Pipeline Underpin Attractive Risk‑Reward and Outperform Rating
PremiumRatings
Nektar Therapeutics: Strong Cash Position and Late‑Stage Autoimmune Pipeline Underpin Attractive Risk‑Reward and Outperform Rating
2M ago
NKTR
Nektar reports Q1 adjusted EPS ($1.82), consensus ($1.48)
PremiumThe Fly
Nektar reports Q1 adjusted EPS ($1.82), consensus ($1.48)
2M ago
NKTR
Is NKTR a Buy, Before Earnings?
PremiumPre-EarningsIs NKTR a Buy, Before Earnings?
2M ago
NKTR
Nektar Therapeutics Prices Upsized Public Equity Offering
Premium
Company Announcements
Nektar Therapeutics Prices Upsized Public Equity Offering
3M ago
8K
NKTR
Nektar 3.5M share Secondary priced at $92.00
Premium
The Fly
Nektar 3.5M share Secondary priced at $92.00
3M ago
NKTR
Nektar price target raised to $95 from $70 at Wedbush
PremiumThe Fly
Nektar price target raised to $95 from $70 at Wedbush
3M ago
NKTR
Nektar price target raised to $151 from $123 at Citi
PremiumThe Fly
Nektar price target raised to $151 from $123 at Citi
3M ago
NKTR
Nektar announces $250M common stock offering
PremiumThe Fly
Nektar announces $250M common stock offering
3M ago
NKTR
Nektar rises 28.2%
PremiumThe Fly
Nektar rises 28.2%
3M ago
NKTR
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
PremiumThe FlyMidday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
3M ago
BX
DX
Nektar rises 19.4%
Premium
The Fly
Nektar rises 19.4%
3M ago
NKTR
Nektar price target raised to $185 from $165 at H.C. Wainwright
Premium
The Fly
Nektar price target raised to $185 from $165 at H.C. Wainwright
3M ago
NKTR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >